Celgene announced a live webcast in September

| By | Celgene, Drug Development, Investments

Celgene Corporation plans to present at two upcoming investor conferences where Celgene management will provide a company overview.

The events will be webcast live and will be available in the Investor Relations section of the company’s website.

On September 6, Celgene to present at Citi’s 13th Annual Biotech Conference and on Friday, September 14, Celgene will present at the Morgan Stanley Global Healthcare Conference.

Celgene Corporation, headquartered in Summit, New Jersey (USA) is an integrated global biopharmaceutical company engaged primarily in the discovery, development and commercialization of innovative therapies for the treatment of cancer and inflammatory diseases through next-generation solutions in protein homeostasis, immuno-oncology, epigenetics, immunology and neuro-inflammation.

SOURCE: businesswire
GMP news
Pharmaceutical industry News and events. Technology transfer and contract manufacturing of medicines.